- call +1-201-465-4211
- email sales@mrinsights.biz
Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection. The infection may occur in a postoperative wound or as a complication unrelated to the disease or condition.
Scope of the Report:
The global Hospital Acquired Infections Control market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital Acquired Infections Control.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Hospital Acquired Infections Control market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital Acquired Infections Control market by product type and applications/end industries.
Market Segment by Companies, this report covers
Advanced Sterilization Products
Becton Dickinson
Belimed AG
bioMerieux
Cantel
Cepheid
Getinge
Merck & Co.
Nordion
Pfizer
Roche
Sakura Seiki
Steris
TSO3
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diagnostic techniques
Dleaning and sterilization
Treatment
Market Segment by Applications, can be divided into
General Hospital
Infectious Disease Hospital
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Hospital Acquired Infections Control Market Overview
1.1 Product Overview and Scope of Hospital Acquired Infections Control
1.2 Classification of Hospital Acquired Infections Control by Types
1.2.1 Global Hospital Acquired Infections Control Revenue Comparison by Types (2017-2023)
1.2.2 Global Hospital Acquired Infections Control Revenue Market Share by Types in 2017
1.2.3 Diagnostic techniques
1.2.4 Dleaning and sterilization
1.2.5 Treatment
1.3 Global Hospital Acquired Infections Control Market by Application
1.3.1 Global Hospital Acquired Infections Control Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 General Hospital
1.3.3 Infectious Disease Hospital
1.4 Global Hospital Acquired Infections Control Market by Regions
1.4.1 Global Hospital Acquired Infections Control Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hospital Acquired Infections Control Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hospital Acquired Infections Control Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital Acquired Infections Control Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hospital Acquired Infections Control Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital Acquired Infections Control Status and Prospect (2013-2023)
1.5 Global Market Size of Hospital Acquired Infections Control (2013-2023)
2 Manufacturers Profiles
2.1 Advanced Sterilization Products
2.1.1 Business Overview
2.1.2 Hospital Acquired Infections Control Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Advanced Sterilization Products Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.2 Becton Dickinson
2.2.1 Business Overview
2.2.2 Hospital Acquired Infections Control Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Becton Dickinson Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.3 Belimed AG
2.3.1 Business Overview
2.3.2 Hospital Acquired Infections Control Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Belimed AG Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.4 bioMerieux
2.4.1 Business Overview
2.4.2 Hospital Acquired Infections Control Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 bioMerieux Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.5 Cantel
2.5.1 Business Overview
2.5.2 Hospital Acquired Infections Control Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cantel Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cepheid
2.6.1 Business Overview
2.6.2 Hospital Acquired Infections Control Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cepheid Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.7 Getinge
2.7.1 Business Overview
2.7.2 Hospital Acquired Infections Control Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Getinge Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck & Co.
2.8.1 Business Overview
2.8.2 Hospital Acquired Infections Control Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck & Co. Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nordion
2.9.1 Business Overview
2.9.2 Hospital Acquired Infections Control Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nordion Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Hospital Acquired Infections Control Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.11 Roche
2.11.1 Business Overview
2.11.2 Hospital Acquired Infections Control Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Roche Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.12 Sakura Seiki
2.12.1 Business Overview
2.12.2 Hospital Acquired Infections Control Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Sakura Seiki Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.13 Steris
2.13.1 Business Overview
2.13.2 Hospital Acquired Infections Control Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Steris Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
2.14 TSO3
2.14.1 Business Overview
2.14.2 Hospital Acquired Infections Control Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 TSO3 Hospital Acquired Infections Control Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hospital Acquired Infections Control Market Competition, by Players
3.1 Global Hospital Acquired Infections Control Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hospital Acquired Infections Control Players Market Share
3.2.2 Top 10 Hospital Acquired Infections Control Players Market Share
3.3 Market Competition Trend
4 Global Hospital Acquired Infections Control Market Size by Regions
4.1 Global Hospital Acquired Infections Control Revenue and Market Share by Regions
4.2 North America Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
4.3 Europe Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
4.5 South America Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
5 North America Hospital Acquired Infections Control Revenue by Countries
5.1 North America Hospital Acquired Infections Control Revenue by Countries (2013-2018)
5.2 USA Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
5.3 Canada Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
5.4 Mexico Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
6 Europe Hospital Acquired Infections Control Revenue by Countries
6.1 Europe Hospital Acquired Infections Control Revenue by Countries (2013-2018)
6.2 Germany Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
6.3 UK Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
6.4 France Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
6.5 Russia Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
6.6 Italy Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hospital Acquired Infections Control Revenue by Countries
7.1 Asia-Pacific Hospital Acquired Infections Control Revenue by Countries (2013-2018)
7.2 China Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
7.3 Japan Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
7.4 Korea Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
7.5 India Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
8 South America Hospital Acquired Infections Control Revenue by Countries
8.1 South America Hospital Acquired Infections Control Revenue by Countries (2013-2018)
8.2 Brazil Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
8.3 Argentina Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
8.4 Colombia Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hospital Acquired Infections Control by Countries
9.1 Middle East and Africa Hospital Acquired Infections Control Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
9.3 UAE Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
9.4 Egypt Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
9.6 South Africa Hospital Acquired Infections Control Revenue and Growth Rate (2013-2018)
10 Global Hospital Acquired Infections Control Market Segment by Type
10.1 Global Hospital Acquired Infections Control Revenue and Market Share by Type (2013-2018)
10.2 Global Hospital Acquired Infections Control Market Forecast by Type (2018-2023)
10.3 Diagnostic techniques Revenue Growth Rate (2013-2023)
10.4 Dleaning and sterilization Revenue Growth Rate (2013-2023)
10.5 Treatment Revenue Growth Rate (2013-2023)
11 Global Hospital Acquired Infections Control Market Segment by Application
11.1 Global Hospital Acquired Infections Control Revenue Market Share by Application (2013-2018)
11.2 Hospital Acquired Infections Control Market Forecast by Application (2018-2023)
11.3 General Hospital Revenue Growth (2013-2018)
11.4 Infectious Disease Hospital Revenue Growth (2013-2018)
12 Global Hospital Acquired Infections Control Market Size Forecast (2018-2023)
12.1 Global Hospital Acquired Infections Control Market Size Forecast (2018-2023)
12.2 Global Hospital Acquired Infections Control Market Forecast by Regions (2018-2023)
12.3 North America Hospital Acquired Infections Control Revenue Market Forecast (2018-2023)
12.4 Europe Hospital Acquired Infections Control Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hospital Acquired Infections Control Revenue Market Forecast (2018-2023)
12.6 South America Hospital Acquired Infections Control Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hospital Acquired Infections Control Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Hospital Acquired Infections Control Picture
Table Product Specifications of Hospital Acquired Infections Control
Table Global Hospital Acquired Infections Control a
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
